ceric oxide has been researched along with Non-alcoholic Fatty Liver Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Monem, AM; Ali, RH; El Agaty, SM; Galal Hamam, G; Lasheen, NN; Lebda, FM | 1 |
| Abdelmottaleb Moussa, SA; Bashandy, SA; El-Seidy, AMA; Elbaset, MA; Ibrahim, FAA | 1 |
| Farías, J; Godoy, K; Reyes, C; Rosas, P; Sandoval, C; Souza-Mello, V | 1 |
| Carvajal, S; Casals, E; Casals, G; Fernández-Varo, G; González de la Presa, B; Jiménez, W; Morales-Ruíz, M; Oró, D; Parra, M; Pastor, Ó; Perramón, M; Puntes, V; Ribera, J | 1 |
| Batiha, GE; El-Sayed, YS; Elewa, YHA; Elshony, N; Hassan, SMA; Hetta, HF; Nassar, AMK; Noreldin, A; Saati, AA; Saleh, H; Samak, D; Shaheen, HM; Umezawa, M; Wasef, L | 1 |
1 review(s) available for ceric oxide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Effectiveness of Cerium Oxide Nanoparticles in Non-Alcoholic Fatty Liver Disease Evolution Using In Vivo and In Vitro Studies: A Systematic Review.
Topics: Cerium; Humans; Liver; Nanoparticles; Non-alcoholic Fatty Liver Disease | 2023 |
4 other study(ies) available for ceric oxide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Dyslipidemias; Fatty Acids, Nonesterified; Female; Fibrosis; Fructose; Humans; Liver; Liver X Receptors; Malondialdehyde; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Ovariectomy; Postmenopause; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Nano cerium oxide and cerium/zinc nanocomposites characterization and therapeutic role in combating obesity via controlling oxidative stress and insulin resistance in rat model.
Topics: Animals; Cerium; Cholesterol; Insulin Resistance; Nanocomposites; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Rats; Triglycerides; Zinc; Zinc Oxide | 2023 |
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Topics: Adipokines; Animals; Body Weight; Cerium; Cholesterol; Choline; Diet; Fatty Acids; Gene Expression Regulation; Inflammation; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine; Nanoparticles; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Wistar; Signal Transduction; Triglycerides | 2019 |
The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosis.
Topics: Animals; Cerium; Lipogenesis; Male; Nanoparticles; Non-alcoholic Fatty Liver Disease; Pyrazoles; Rats | 2021 |